Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
2
18%
Ph not_applicable
8
73%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(6)
Terminated(2)
Other(3)

Detailed Status

Completed6
unknown3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (9.1%)
Phase 22 (18.2%)
N/A8 (72.7%)

Trials by Status

completed655%
unknown327%
terminated19%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11